C. E. van der Schoot

Combining Hypermethylated RASSF1A Detection Using ddPCR with miR-371a-3p Testing: An Improved Panel of Liquid Biopsy Biomarkers for Testicular Germ Cell Tumor Patients

L. Looijenga, A. Gillis, C. E. van der Schoot, 2021, Cancers.

Mesenchymal Neuroblastoma Cells Are Undetected by Current mRNA Marker Panels: The Development of a Specific Neuroblastoma Mesenchymal Minimal Residual Disease Panel

R. Versteeg, H. Caron, J. Koster, 2019, JCO precision oncology.

Detecting minimal residual disease in neuroblastoma: the superiority of a panel of real-time quantitative PCR markers.

F. Berthold, R. Versteeg, H. Caron, 2009, Clinical chemistry.

Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations

Gudrun Schleiermacher, Jan Koster, Javed Khan, 2015, Nature Genetics.

Targeted locus amplification to develop robust patient-specific assays for liquid biopsies in pediatric solid tumors

F. Holstege, E. Splinter, J. Molenaar, 2023, Frontiers in Oncology.

Improving Risk Stratification for Pediatric Patients with Rhabdomyosarcoma by Molecular Detection of Disseminated Disease

C. E. van der Schoot, M. V. van Noesel, G. Tytgat, 2021, Clinical Cancer Research.